DNAnexus Selected as Platform Provider of the Trusted Research Environment for UK’s Largest Health Research Program
DNAnexus,the leading provider of cloud-based genomic and biomedical data access and companion analysis software,announced that it has been awarded a three-year contract by Our Future Health. The DNAnexus platform, which will be hosted in the UK, will provide approved researchers with a scalable, cloud-based trusted research environment for accessing and analyzing Our Future Health’s growing biomedical dataset and tools to drive biological insights and global collaborations to advance precision medicine.
Our Future Health is an ambitious collaboration among the public, private, and non-profit sectors designed to help scientists develop new ways to prevent, detect, and treat disease. The program aims to recruit up to 5 million adult volunteers, which is more than 9% of the adult population in the UK. Approved researchers from the global life sciences, healthcare, and academic communities will be able to use the DNAnexus platform to securely explore and analyze the de-identified data.
Andrew Roddam, CEO of Our Future Health, said: “We’re delighted that DNAnexus will be delivering our trusted research environment. It’s an incredibly important decision because providing an environment for researchers to work with participants’ data in a safe, secure, and controlled way is a top priority for Our Future Health. DNAnexus will be a really important partner as we work towards achieving our goal to help researchers develop new ways to prevent, detect, and treat diseases.”
Today, DNAnexus has more than 12,000 platform users across 48 countries and counts seven of the top 10 pharmaceutical and eight of the top 10 diagnostic companies as customers. The company built and continues to support the Research Analysis Platform for the UK Biobank, another large-scale biomedical resource that contains in-depth genetic and health information from half a million UK participants. The protected cloud environment was designed to meet the most rigorous standards for data quality, scalability, security, privacy, and safety.
“Our Future Health will be a huge step forward for genomic-based science in the UK and around the world. We are very excited that this ambitious health research program, the largest of its kind, will utilize the power of our industry-leading biomedical data analysis platform and expertise,” said Richard Daly, CEO at DNAnexus. “Together with Our Future Health and the UK Biobank, we are proud to be the partner of choice for transformative population research programs, and we look forward to empowering more researchers to accelerate the era of precision medicine.”
Recommended AI News: HP Unlocks Possibilities for Gamers to Play Anywhere, Longer, and Better
[To share your insights with us, please write to firstname.lastname@example.org]